Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia

Abstract excerpt

BACKGROUND: Hereditary hemorrhagic telangiectasia (HHT) is a rare vascular dysplasia resulting in visceral arteriovenous malformations and smaller mucocutaneous telangiectasia. Most patients experience recurrent nosebleeds and become anemic without iron supplementation. However, thousands may require anticoagulation for conditions such as venous thromboembolism and/or atrial fibrillation. Over decades, tolerance...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Vascular Anomalies and Treatments